Patient-Directed Antimicrobial Duration in Acute Uncomplicated Pyelonephritis
Status:
Recruiting
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
This pilot study will randomize 40 female patients with acute uncomplicated pyelonephritis to
receive standard duration of therapy versus patient-directed antimicrobial duration (PDAD).
The primary objectives of this pilot trial are to determine the feasibility and safety of
conducting a full-scale multi-center randomized controlled trial.